aTyr Pharma Inc banner

aTyr Pharma Inc
NASDAQ:ATYR

Watchlist Manager
aTyr Pharma Inc Logo
aTyr Pharma Inc
NASDAQ:ATYR
Watchlist
Price: 0.8469 USD -0.46%
Market Cap: $83m

Wall Street
Price Targets

ATYR Price Targets Summary
aTyr Pharma Inc

There are no price targets for ATYR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
aTyr Pharma Inc Competitors:
Price Targets
RLMD
Relmada Therapeutics Inc
109% Upside
TENB
Tenable Holdings Inc
75% Upside
VAC
Pierre et Vacances SA
38% Upside
ZNTL
Zentalis Pharmaceuticals Inc
86% Upside

Revenue
Forecast

N/A
Past Growth
579% / Year
Estimated Growth
Estimates Accuracy
22%
Average Beat
N/A
Past Growth
579% / Year
Estimated Growth
Estimates Accuracy
22%
Average Beat

The compound annual growth rate of aTyr Pharma Inc's revenue for the next 3 years is 579%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-93%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-93%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ATYR's stock price target?
Not Available

ATYR doesn't have any price targets made by Wall Street professionals.

What is aTyr Pharma Inc's Revenue forecast?
Projected CAGR
579%

The compound annual growth rate of aTyr Pharma Inc's revenue for the next 3 years is 579%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett